there is a 'real risk' of coronavirus epicenters shifting globally again: expert | street signs asia
Published 4 years ago • 742 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
2:31
there is a 'severity bias' in the us' coronavirus case count: pathogen expert | street signs asia
-
3:08
lockdowns only buy response time, not solve health crises, says expert | street signs asia
-
3:46
coronavirus could have serious consequences for maldives' local population | street signs asia
-
2:06
'not such a good idea' to fast-track a coronavirus vaccine, says infectious diseases expert
-
2:41
no government is providing enough support for the virus' economic blow: expert | street signs asia
-
17:57
how biontech used cancer research to create its covid vaccine
-
11:09
covid vaccine race has u.s. states scrambling for funding: cnbc after hours
-
13:23
how keeping connected could lead to higher power prices | the business | abc news
-
2:16
which sectors could investors target during the coronavirus crisis? | street signs asia
-
2:15
asean markets likely to suffer post-coronavirus: strategist | street signs asia
-
2:27
coronavirus impact will be felt mostly in asia-pacific region: expert | capital connection
-
3:06
novel coronavirus not caused by a genetic mutation: expert
-
4:30
vaccines can take months before they're ready for the public: expert
-
3:53
coronavirus: we're in the second inning for vaccine development, expert says
-
3:11
covid-19 crisis is a 'distraction,' says strategist | street signs asia
-
0:54
fda grants full approval for pfizer's coronavirus vaccine
-
9:22
booster shots and vaccine mandates: the new plan to beat covid-19
-
2:48
china's 2020 growth could contract by 2-3% without further stimulus: barclays | street signs asia
-
2:59
pathogen expert calls coronavirus crisis the 'disease x of the century' | street signs asia
-
2:21
health systems weigh covid-19 vaccine mandates for employees
-
0:28
#covid protocols to change for #bayarea #healthcare workers • #syncedin #masks #vaccines
-
1:35
states rush to secure distribution funding ahead of covid-19 vaccine approval